Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180048 · ClinicalTrials.gov registry record · NA
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02180048 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 55 participants.
The verdict
NCT02180048, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to observe effects of caffeine on overactive bladder symptoms and wellbeing. This study looks at whether caffeine has bad effects on urinary symptoms or if lower doses of caffeine decrease the effects. The study will propose the following hypothesis: 1. The voiding and mental health symptoms will be greatest in the high dose treatment and lowest in the placebo treatment. 2. The low dose treatment will produce more voiding and mental health symptoms than the placebo treatment. 3. Voiding and mental health symptoms will be mediated by hydration status of the patient which will be assessed using a Tanita Scale.
Interventions
- DIETARY_SUPPLEMENT 400 mg of caffeine/day (Two 200mg pills/day)
- DIETARY_SUPPLEMENT 200 mg of caffeine/day (One 200mg pill and one placebo pill)
- DIETARY_SUPPLEMENT Two placebo pills/day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02180048
The ClinicalTrials.gov registry entry for NCT02180048 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 400 mg of caffeine/day (Two 200mg pills/day) is the first listed.
NCT02180048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02180048 about?
NCT02180048 is a clinical study titled ""The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"". The purpose of this study is to observe effects of caffeine on overactive bladder symptoms and wellbeing. This study looks at whether caffeine has bad effects on urinary symptoms or if lower doses of caffeine decrease the effects. The study will propose the following hypothesis: 1. The voiding and...
What is the current status of trial NCT02180048?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2014-07. Estimated completion is 2018-09-20.
What interventions are being tested in trial NCT02180048?
The interventions under investigation include: 400 mg of caffeine/day (Two 200mg pills/day) (DIETARY_SUPPLEMENT), 200 mg of caffeine/day (One 200mg pill and one placebo pill) (DIETARY_SUPPLEMENT), Two placebo pills/day (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02180048?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.